These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 1062798

  • 1. A new group of potent inducers of differentiation in murine erythroleukemia cells.
    Reuben RC, Wife RL, Breslow R, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1976 Mar; 73(3):862-6. PubMed ID: 1062798
    [Abstract] [Full Text] [Related]

  • 2. Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells.
    Fibach E, Reuben RC, Rifkind RA, Marks PA.
    Cancer Res; 1977 Feb; 37(2):440-4. PubMed ID: 264411
    [Abstract] [Full Text] [Related]

  • 3. Inducers of erythroleukemic differentiation. Relationship of structure to activity among planar-polar compounds.
    Reuben RC, Khanna PL, Gazitt Y, Breslow R, Rifkind RA, Marks PA.
    J Biol Chem; 1978 Jun 25; 253(12):4214-8. PubMed ID: 275252
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of chemical inducers on expression of beta globin genes in murine erythroleukemia cells.
    Nudel U, Salmon JE, Terada M, Bank A, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1977 Mar 25; 74(3):1100-4. PubMed ID: 265555
    [Abstract] [Full Text] [Related]

  • 5. Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases.
    Watanabe T, Kondo K, Oishi M.
    Cancer Res; 1991 Feb 01; 51(3):764-8. PubMed ID: 1988116
    [Abstract] [Full Text] [Related]

  • 6. Studies on the mechanism of action of hexamethylene bisacetamide, a potent inducer of erythroleukemic differentiation.
    Reuben RC.
    Biochim Biophys Acta; 1979 Dec 11; 588(3):310-21. PubMed ID: 292456
    [Abstract] [Full Text] [Related]

  • 7. Induction of differentiation in Friend erythroleukemia cells with dimethyl sulfoxide, hexamethylene bisacetamide and sodium butyrate is not accompanied by changes in proviral DNA or its expression.
    Zajac-Kaye M, Brown E, Friend C.
    Virus Res; 1986 Oct 11; 6(1):45-55. PubMed ID: 3467519
    [Abstract] [Full Text] [Related]

  • 8. Comparative study of two groups of inducers of Friend erythroleukemia cell differentiation in a chemically defined medium.
    Gazitt Y.
    Cancer Res; 1981 Mar 11; 41(3):1184-6. PubMed ID: 6936075
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ureido derivatives of pyridine: a new class of inducers of murine erythroleukemia cell differentiation.
    Pappas IS, Niopas I, Tsiftsoglou AS.
    Anticancer Drug Des; 1992 Apr 11; 7(2):153-61. PubMed ID: 1575888
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis of globin mRNA in relation to the cell cycle during induced murine erythroleukemia differentiation.
    Gambari R, Terada M, Bank A, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1978 Aug 11; 75(8):3801-4. PubMed ID: 278991
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of induced L-ornithine decarboxylase stimulation and erythrodifferentiation in Friend erythroleukemia cells by 2',5'-isoadenylate trimer core.
    Gazitt Y.
    Cancer Res; 1981 Jul 11; 41(7):2959-61. PubMed ID: 6941849
    [Abstract] [Full Text] [Related]

  • 17. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
    Waxman S, Scher BM, Hellinger N, Scher W.
    Cancer Res; 1990 Jul 01; 50(13):3878-87. PubMed ID: 2354439
    [Abstract] [Full Text] [Related]

  • 18. Induction of erythroid differentiation in murine erythroleukemia cells by N-substituted polymethylene diamides.
    Hozumi T, Nomura J, Ishizawa M.
    Int J Cancer; 1979 Jan 15; 23(1):119-22. PubMed ID: 282269
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Polar/apolar compounds induce leukemia cell differentiation by modulating cell-surface potential.
    Arcangeli A, Carlà M, Del Bene MR, Becchetti A, Wanke E, Olivotto M.
    Proc Natl Acad Sci U S A; 1993 Jun 15; 90(12):5858-62. PubMed ID: 8516337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.